Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
22 July 2004Website:
http://www.neurometrix.comNext earnings report:
26 July 2024Last dividends:
28 March 2007Next dividends:
N/APrice
after hours | Fri, 05 Jul 2024 20:57:52 GMTDividend
Analysts recommendations
Institutional Ownership
NURO Latest News
NeuroMetrix, Inc. (NURO) Q4 2023 Earnings Call Transcript
NeuroMetrix announced today that the Company's Chairman and CEO, Dr. Shai N. Gozani will present at the Emerging Growth Conference on January 10, 2024.
WOBURN, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), announced today that it will present at the Emerging Growth Conference on October 4, 2023.
WOBURN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), announced today that it will present at the Emerging Growth Conference on September 6, 2023. This live, interactive, online event will give shareholders and the investment community the opportunity to interact in real time with the Company's Chairman and Chief Executive Officer, Dr. Shai N. Gozani. Dr. Gozani will present business highlights and recent developments, including the evolution of its Quell® neuromodulation technology. He will be available for questions from conference participants.
WOBURN, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its Q2 2023 business and financial highlights before the opening of the market on July 27, 2023. The Company will host a conference call at 8:00 a.m., Eastern Time on July 27, 2023.
NeuroMetrix, Inc. (NASDAQ:NURO ) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET Company Participants Thomas Higgins - SVP, CFO & Treasurer Shai Gozani - Founder, Chairman, CEO, President & Secretary Conference Call Participants Operator Good morning, and welcome to the NeuroMetrix First Quarter 2023 Earnings Call. My name is Levay, and I'll be your moderator on the call.
WOBURN, Mass., April 28, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2023 first quarter financial results before the opening of the market on May 3, 2023. The Company will host a conference call at 8:00 a.m., Eastern Time on May 3, 2023 to discuss its financial results as well as business developments affecting the Company.
What type of business is NeuroMetrix?
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
What sector is NeuroMetrix in?
NeuroMetrix is in the Healthcare sector
What industry is NeuroMetrix in?
NeuroMetrix is in the Medical Devices industry
What country is NeuroMetrix from?
NeuroMetrix is headquartered in United States
When did NeuroMetrix go public?
NeuroMetrix initial public offering (IPO) was on 22 July 2004
What is NeuroMetrix website?
https://www.neurometrix.com
Is NeuroMetrix in the S&P 500?
No, NeuroMetrix is not included in the S&P 500 index
Is NeuroMetrix in the NASDAQ 100?
No, NeuroMetrix is not included in the NASDAQ 100 index
Is NeuroMetrix in the Dow Jones?
No, NeuroMetrix is not included in the Dow Jones index
When does NeuroMetrix report earnings?
The next expected earnings date for NeuroMetrix is 26 July 2024